Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
BTC vs ETH fundamentals: a side-by-side look at core strengths and weaknesses to inform your next move.
27,640 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Geneva hosts a fresh round of U.S.-Iran nuclear talks as regional tensions rise. Markets respond with shifts in oil p...
A BAFTA ceremony moment involving Tourette syndrome sparked a global debate on stigma and language. This report exami...
The Metals Company aims to unlock a vast resource of nickel, cobalt, copper, and manganese. In 2026, whether it’s a b...
Regencell Bioscience sits in the high-risk, high-reward world of early-stage biotech. Before you consider investing, ...
Oil futures fell about 8% as energy ministers prepared to discuss emergency reserve releases. The move comes amid ong...
When a single DeFi trade went wrong, a crypto trader faced staggering losses as slippage and liquidity gaps magnified...
Mastercard plans to buy London-based BVNK for up to $1.8 billion, creating the largest stablecoin deal to date and ac...
The United States crossed $39 trillion in gross debt, a milestone critics call a warning sign of stubborn deficits. W...
A fresh take on spotting a possible dark-horse in the driverless vehicle arena. Learn the signals, risks, and how to ...
Progressive lawmakers unveiled a bill to halt new data centers for two years while federal safeguards for energy, lab...
Red Cat Holdings posted a record Q4 revenue of $26.2 million and full-year $40.7 million, but margins stayed thin and...